
Expansion of Y-Logimed’s Partnership with Abbott Medical through the Introduction of Innovative Product Technologies & Honorary Award for the Third Consecutive Year
Y-Logimed, a member of the Hellenic Healthcare Group (HHG), the largest private healthcare services Group in Greece, has been honored for the third consecutive year by Abbott Medical at the Sales Award Meeting “Heart and Soul – Blue Fire Burns Brightest,” held from January 13 to 16, 2025, in Monte Carlo.
This recognition highlights Y-Logimed’s outstanding performance and collaboration with Abbott Medical for 2024. Since 2014, Y-Logimed is the official distributor of Abbott Medical in Greece. Abbott Medical ranks among the top 10 global manufacturers of medical technology products.
Through this long-standing partnership, Y-Logimed’s Cardiovascular division manages an extensive portfolio of cutting-edge Abbott Medical products, specializing in coronary, peripheral & angio surgery interventions.
In 2024, Y-Logimed was also appointed official distributor of Abbott Medical’s innovative OAS – Orbital Atherectomy System technology in the Greek market. This system leverages centrifugal force and pulsatile vibrations to effectively treat severely calcified lesions in coronary and peripheral vessels.
Starting January 1, 2025, Y-Logimed is further expanding Abbott Medical’s product portfolio by incorporating new technologies, including Optical Coherence Tomography (OCT), Fractional Flow Reserve (FFR), Coronary Flow Reserve (CFR), and Microcirculation (IMR) assessment using the thermodilution method. These advancements significantly enhance Y-Logimed’s presence in the field of cardiology in Greece, offering personalized solutions that improve diagnostic accuracy, procedural efficiency, and ultimately, patient quality of life.
Y-Logimed’s CEO, Mr. Spyridon Mavrantonis, stated:
“Receiving Abbott Medical’s award for the third consecutive year is an honor for our team and recognition to our commitment to achieving our goals. At the same time, the expansion of our partnership with Abbott Medical confirms its trust in Y-Logimed. Our company continues to invest in adopting innovative technologies, strengthening our role as a key partner for healthcare professionals, and contributing to the continuous improvement of medical services in Greece.”